Allan Shaw - 19 Aug 2022 Form 4 Insider Report for Blue Water Vaccines Inc. (ONCO)

Reporting relationship: Director
Issuer ticker: ONCO
Reported as of: 19 Aug 2022
Net transaction value: -$116,766
SEC form: 4
Accepted by SEC: 23 Aug 2022, 16:39:56 UTC
Prior SEC filing: 27 May 2022
Next SEC filing: 22 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Allan Shaw

Key filing fact

Allan Shaw filed Form 4 for Blue Water Vaccines Inc. (ONCO) on 23 Aug 2022.

Key facts

This page summarizes Allan Shaw's Form 4 filing for Blue Water Vaccines Inc. (ONCO).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 23 Aug 2022, 16:39.

Change

Previous filing in this sequence was filed on 27 May 2022.
Current net transaction value: -$116,766.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BWV transaction

Common Stock

Tax liability

Transaction value: $296
Shares: +29,636
Change %
Price: $0.0100^*
Shares after: 29,636
Date: 19 Aug 2022
Ownership: Direct

BWV transaction

Common Stock

Sale

Transaction value: $116,766
Shares: -29,636
Change %: -100%
Price: $3.94
Shares after: 0
Date: 19 Aug 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BWV transaction Derivative

Stock Option

Tax liability

Transaction value: $296
Shares: -29,636
Change %: -65%
Price: $0.0100^*
Shares after: 16,284
Date: 19 Aug 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 29,636
Exercise price: $0.0100

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Allan Shaw is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

The Common Stock reported herein were sold by the reporting person at a high price of $4.02, a low price of $3.91 and an average price of $3.94 per share of Common Stock. Upon request, the reporting person will provide details of each sale.